DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2020 Jan 23

PMID 31963554

Citations 15

Authors

Sungsin Jo

Subin Yoon

So Young Lee

So Yeon Kim

Hyosun Park

Jinil Han

Sung Hoon Choi

Joong-Soo Han

Jae-Hyuk Yang

Tae-Hwan Kim

Affiliations

Soon will be listed here.

Abstract

1α,25-dihydroxyvitamin D3 (1,25D3), the most popular drug for osteoporosis treatment, drives osteoblast differentiation and bone mineralization. Wnt/β-catenin signaling is involved in commitment and differentiation of osteoblasts, but the role of the Dickkopf-related protein 1 (DKK1), a Wnt antagonist, in osteoblasts remains unknown. Here, we demonstrate the molecular mechanism of DKK1 induction by 1,25D3 and its physiological role during osteoblast differentiation. 1,25D3 markedly promoted the expression of both CCAAT/enhancer binding protein beta (C/EBPβ) and DKK1 at day 7 during osteoblast differentiation. Interestingly, mRNA and protein levels of C/EBPβ and DKK1 in osteoblasts were elevated by 1,25D3. We also found that C/EBPβ, in response to 1,25D3, directly binds to the human DKK1 promoter. Knockdown of C/EBPβ downregulated the expression of DKK1 in osteoblasts, which was partially reversed by 1,25D3. In contrast, overexpression of C/EBPβ upregulated DKK1 expression in osteoblasts, which was enhanced by 1,25D3. Furthermore, 1,25D3 treatment in osteoblasts stimulated secretion of DKK1 protein within the endoplasmic reticulum to extracellular. Intriguingly, blocking DKK1 attenuated calcified nodule formation in mineralized osteoblasts, but not ALP activity or collagen synthesis. Taken together, these observations suggest that 1,25D3 promotes the mineralization of osteoblasts through activation of DKK1 followed by an increase of C/EBPβ.

Citing Articles

TGF-β signaling regulates differentiation of MSCs in bone metabolism: disputes among viewpoints.

Wei E, Hu M, Wu L, Pan X, Zhu Q, Liu H Stem Cell Res Ther. 2024; 15(1):156.

PMID: 38816830 PMC: 11140988. DOI: 10.1186/s13287-024-03761-w.

The Long, Dynamic Journey to the Elucidation of the Links Between Inflammation, Ectopic Bone Formation, and Wnt Signaling in Ankylosing Spondylitis.

Kwon S J Rheum Dis. 2023; 29(1):1-3.

PMID: 37476699 PMC: 10324921. DOI: 10.4078/jrd.2022.29.1.1.

The TNF-NF-kB-DKK1 Axis Promoted Bone Formation in the Enthesis of Ankylosing Spondylitis.

Jo S, Nam B, Lee Y, Park H, Weon S, Choi S J Rheum Dis. 2023; 28(4):216-224.

PMID: 37476360 PMC: 10324906. DOI: 10.4078/jrd.2021.28.4.216.

Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts.

van Driel M, van Leeuwen J Nutrients. 2023; 15(3).

PMID: 36771187 PMC: 9919888. DOI: 10.3390/nu15030480.

MRL/MpJ Mice Resist to Age-Related and Long-Term Ovariectomy-Induced Bone Loss: Implications for Bone Regeneration and Repair.

Gao X, Sun X, Cheng H, Ruzbarsky J, Mullen M, Huard M Int J Mol Sci. 2023; 24(3).

PMID: 36768718 PMC: 9916619. DOI: 10.3390/ijms24032396.

References

Gutierrez S, Javed A, Tennant D, van Rees M, Montecino M, Stein G . CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem. 2001; 277(2):1316-23. DOI: 10.1074/jbc.M106611200. View

Li X, Wang J, Zhan Z, Li S, Zheng Z, Wang T . Inflammation Intensity-Dependent Expression of Osteoinductive Wnt Proteins Is Critical for Ectopic New Bone Formation in Ankylosing Spondylitis. Arthritis Rheumatol. 2018; 70(7):1056-1070. DOI: 10.1002/art.40468. View

Krishnan V, Bryant H, MacDougald O . Regulation of bone mass by Wnt signaling. J Clin Invest. 2006; 116(5):1202-9. PMC: 1451219. DOI: 10.1172/JCI28551. View

Kim H, Park J, Won H, Lee J, Kong G . CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway. FASEB J. 2014; 29(1):300-13. DOI: 10.1096/fj.14-253997. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Marchwicka A, Marcinkowska E . Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines. Int J Mol Sci. 2018; 19(7). PMC: 6073189. DOI: 10.3390/ijms19071918. View

DAmico L, Mahajan S, Capietto A, Yang Z, Zamani A, Ricci B . Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer. J Exp Med. 2016; 213(5):827-40. PMC: 4854727. DOI: 10.1084/jem.20150950. View

Pike J, Meyer M, Benkusky N, Lee S, St John H, Carlson A . Genomic Determinants of Vitamin D-Regulated Gene Expression. Vitam Horm. 2016; 100:21-44. PMC: 5113140. DOI: 10.1016/bs.vh.2015.10.011. View

Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y . Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet. 2005; 37(9):945-52. DOI: 10.1038/ng1614. View

10.

Nakamichi Y, Udagawa N, Horibe K, Mizoguchi T, Yamamoto Y, Nakamura T . VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption. J Bone Miner Res. 2017; 32(6):1297-1308. DOI: 10.1002/jbmr.3096. View

11.

Tominaga H, Maeda S, Hayashi M, Takeda S, Akira S, Komiya S . CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol Biol Cell. 2008; 19(12):5373-86. PMC: 2592674. DOI: 10.1091/mbc.e08-03-0329. View

12.

Bischoff-Ferrari H, Willett W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B . Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005; 293(18):2257-64. DOI: 10.1001/jama.293.18.2257. View

13.

Arensman M, Nguyen P, Kershaw K, Lay A, Ostertag-Hill C, Sherman M . Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer. Mol Cancer Res. 2015; 13(11):1509-19. PMC: 4644680. DOI: 10.1158/1541-7786.MCR-15-0204. View

14.

Meyer M, Benkusky N, Lee C, Pike J . Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation. J Biol Chem. 2014; 289(28):19539-54. PMC: 4094065. DOI: 10.1074/jbc.M114.578104. View

15.

Gaffney-Stomberg E, Lutz L, Shcherbina A, Ricke D, Petrovick M, Cropper T . Association Between Single Gene Polymorphisms and Bone Biomarkers and Response to Calcium and Vitamin D Supplementation in Young Adults Undergoing Military Training. J Bone Miner Res. 2016; 32(3):498-507. DOI: 10.1002/jbmr.3008. View

16.

Bjork A, Mellstrom D, Ohlsson C, Karlsson M, Mallmin H, Johansson G . Haplotypes in the CYP2R1 gene are associated with levels of 25(OH)D and bone mineral density, but not with other markers of bone metabolism (MrOS Sweden). PLoS One. 2018; 13(12):e0209268. PMC: 6303094. DOI: 10.1371/journal.pone.0209268. View

17.

Plate L, Wiseman R . Regulating Secretory Proteostasis through the Unfolded Protein Response: From Function to Therapy. Trends Cell Biol. 2017; 27(10):722-737. PMC: 5612838. DOI: 10.1016/j.tcb.2017.05.006. View

18.

Yao G, Wu J, Troiano N, Insogna K . Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice. J Bone Miner Metab. 2010; 29(2):141-8. PMC: 3457021. DOI: 10.1007/s00774-010-0202-3. View

19.

Hoeppner L, Secreto F, Westendorf J . Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets. 2009; 13(4):485-96. PMC: 3023986. DOI: 10.1517/14728220902841961. View

20.

Jo S, Lee J, Han J, Lee B, Kang S, Hwang K . Identification and characterization of human bone-derived cells. Biochem Biophys Res Commun. 2017; 495(1):1257-1263. DOI: 10.1016/j.bbrc.2017.11.155. View